Corporate Highlights
- Principal is a high-growth opportunity to participate in the healthcare technologies field.
- Strategy is to capitalize on arbitrage situations by acquiring healthcare technology companies with proven and world-leading technologies in the EU, expanding sales globally and taking advantage of significantly higher valuations in North America.
- High profile management team and advisors.
- Exclusive access to acquisitions.
- Access to significant EU capital.
- Trades on TSXV – ‘PTEC.V’
In the next 12 months, Principal plans to acquire a substantial private healthcare technology company which will transform PTEC.V and provide a platform for future growth and profitability.
Executive Team
Jerry Trent
Jerry Trent
President / CEO / Board of Directors
Founder Multi Family Office for Direct Investments
Head of Global Markets & Investment Banking (Sberbank)
Head of M&A / Member Global Deals Origination Group (PwC)
Wall Street Investor and Portfolio Manager
Prince Alfred of Liechtenstein
Chairman Board of Directors
Senior Member of the Princely Family of Liechtenstein
Numerous Board of Directors and Supervisory Board positions, including at LGT Group (largest family-owned asset management group globally)
Renowned author of numerous books and articles
Dr. Leopold Specht
Board of Directors
Founder Specht & Partner (Interntl. Corp. Law Firm)
Member Economic Council Harvard Institute for Global Law (Harvard Law School)
Numerous Board of Directors positions
Peter McKeown
CFO
Numerous Board of Directors positions
Serial Entrepreneur in the areas of Technology and Resources
Founder and Senior Executive of multiple listed companies
Dr. Gerald Rainer
Chairman Board of Advisors
CEO Julius Baer (Multi-billion Asset Manager Switzerland)
Multiple board and trustee positions on multi-billion dollar entities and trusts
Serial Entrepreneur
Dr. Ivo Ivanovski
Board of Advisors
IT Minister of the Republic of Macedonia
CEO of exchange-listed Tower Co. of A1 Telekom Austria Group
Director M&A and Regulatory Telekom Austria Group
Numerous Board of Directors positions
Among others Distinguished Silver Star Award from International Telecommunication Union
Rick Geoffrion
Board of Advisors
Serial Entrepreneur in healthcare technologies space with over 35 years of experience in the industry
Vice-Chairman Mullings-Group (leading executive search firm Healthcare / Med-Tech / Life Sciences)
Numerous board positions in healthcare technology companies
Investors
Increasing PTEC.V Share Value
- Purchase control of private and established EU healthcare technology companies with leading and disruptive healthcare technologies.
- Finance acquisitions using combination of equity and debt.
- Principal adds management, marketing expertise and growth capital to expand operations and roll-out sales internationally.
- Acquisitions’ increasing financial performance leads to higher share values.
- Purchasing EU healthcare technology businesses at a discount and exposing them to North-American market valuations leads to higher share values.
- Paying off debt with increased cash flows, and new equity when capital markets are advantageous, leads to higher share values.
- Repeat process for other attractive Acquisition Targets.
Deal Flow
- Access to Acquisition Targets:
- Principals’ Directors, Advisors and major shareholder are highly visible and connected in the EU healthcare technology space.
- Principal team with exclusive access to key opinion leaders and high-profile international medical advisory boards.
- Principal owns a Clinical Research Organization in the EU healthcare technology space which provides ongoing access to proven and world-leading technologies.
In the next 12 months, Principal plans to acquire a substantial private healthcare technology company which will transform PTEC.V and provide a platform for future growth and profitability.
Share Structure
| COMMON SHARES | |
| Major. Shareholder – GreenIsland | 12,500,000 |
| Float | 10,375,461 |
| Shares Outstanding | 22,875,461 |
| STOCK OPTIONS | |
| Executive Team (~$0.14 options expire 2031) | 1,850,000 |
| CEO ($0.12 options expire 2033) | 2,325,000 |
| WARRANTS ($0.12 warrants expire July 2026) | 3,011,537 |
| FULLY DILUTED | 30,061,998 |
| COMMON SHARES | |
| Major. Shareholder – GreenIsland | 12,500,000 |
| Float | 10,375,461 |
| Shares Outstanding | 22,875,461 |
| STOCK OPTIONS | |
| Executive Team (~$0.14 options exp. 2031) | 1,850,000 |
| CEO ($0.12 options exp. 2033) | 2,325,000 |
| WARRANTS ($0.12 warrants expire July 2026) | 3,011,537 |
| FULLY DILUTED | 30,061,998 |
Acquisitions to Date
E&E CRO
- An 80% owned Clinical Research Organization which facilitates the international distribution permits process for healthcare technology companies and allows to build a unique and highly valuable database.
- E&E is a strategic investment made to facilitate exclusive access to Acquisition Targets, set them up for international rollout as well as to provide a highly experienced in-house technical due diligence team to Principal.
- Operations based in the EU.
- Stable revenues and cash flow positive.
Vision Surgery AI
- Vision’s Technology uses advanced Computer Vision- and AI Technology to monitor surgical teams and operating room equipment in real-time to ensure that fatalities and complications are reduced to a minimum, while building a large database of medical information.
- The AI Technology detects and alerts any anomaly and deviation from a perfectly performed surgery, thereby saving lifes as 80% of fatalities during surgeries stem from human error and the human error factor is practically eliminated with this advanced technology.
- A minor equity investment with capability to expand ownership interest as operations increase.
News
Videos
Be the first to know. Sign up for Updates.
Contact
- Principal Technologies Inc. 700 W Georgia Street #2500Vancouver, Canada
- frame@principal-technologies.com
- +1 587 225 2599
- Principal Technologies Capital Management Tuchlauben 7A1010 Vienna, Austria
- office@principal-technologies.com
- +43 1 25 300 25 210